跳至主要内容
临床试验/JPRN-UMIN000004322
JPRN-UMIN000004322已完成未知

A relationship between linezolid-induced myelosuppression and blood linezolid concentrations in methicillin-resistant staphylococcus aureus (MRSA) infection; an open-label, non-randomized study - A relationship between linezolid-induced myelosuppression and blood linezolid concentrations in MRSA infection

Kanazawa University Hospital0 个研究点目标入组 28 人开始时间: 2010年10月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
28

研究概览

简要总结

Our clinical study indicated that multiple doses of rifampicin (RFP) reduced the dose-normalized trough concentration of linezolid (LZD) at the first assessment day by an average of 65%.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) history of hypersensitivity to ZYVOX 2) pregnancy, parturition or lactation 3) other situation that doctor decides

研究者

相似试验

A relationship between linezolid-induced... | 临床试验